GlassScriptPhysician profile
Jeffrey Findling
NPI 1558685289
$1,683.89
in general payments reported to CMS, 2019-2025
18 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $92.15 · 2021: $239 · 2022: $224 · 2023: $283 · 2024: $232 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $438.37 | 2021-2025 | Simplimax, Puraply, Via Matrix |
| Abbott Laboratories | $254.11 | 2019-2024 | Proclaim, Axium |
| Paratek Pharmaceuticals, INC. | $198.94 | 2019-2024 | Nuzyra |
| Horizon Therapeutics Plc | $193.03 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $169.29 | 2019-2025 | Collagenase Santyl, Regranex |
| Amgen INC. | $115.74 | 2024-2025 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $57.47 | 2022-2023 | Seglentis |
| Kerecis Limited | $48.09 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Integra Lifesciences Corporation | $32.70 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Nevro Corp. | $29.43 | 2022 | |
| Treace Medical Concepts, INC. | $25.64 | 2025 | |
| Convatec INC. | $21.23 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $19.55 | 2023 | Vibativ |
| Abbvie INC. | $18.97 | 2024 | |
| Hartmann USA, INC. | $18.82 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $17.40 | 2022 | |
| Reprise Biomedical, INC. | $14.19 | 2024 | Miro3d |
| Arthrosurface Incorporated | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Findling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.